ATHIRA PHARMA INC (ATHA)
US04746L1044 - Common Stock
ChartMill assigns a Buy % Consensus number of 78% to ATHA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.57. This target is 276.37% above the current price.
ATHA was analyzed by 12 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about ATHA.
In the previous month the buy percentage consensus was at a similar level.
ATHA was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-11 | JMP Securities | Maintains | Outperform -> Outperform |
| 2023-05-15 | Mizuho | Maintains | Buy -> Buy |
| 2023-03-30 | BTIG | Maintains | Buy |
| 2023-03-24 | JMP Securities | Reiterate | Market Outperform |
| 2022-07-07 | Mizuho | Initiate | Buy |
| 2022-06-23 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2022-06-23 | Stifel | Downgrade | Buy -> Hold |
| 2022-06-23 | Jefferies | Downgrade | Buy -> Hold |
| 2022-05-10 | BTIG | Initiate | Buy |
| 2022-04-21 | Berenberg | Initiate | Buy |
| 2021-12-15 | Goldman Sachs | Initiate | Neutral |